164 related articles for article (PubMed ID: 34692850)
1. Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-
Chen R; Qian H; Yuan X; Chen S; Liu Y; Wang B; Shi G
J Immunol Res; 2021; 2021():1017938. PubMed ID: 34692850
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis.
Dulic S; Vasarhelyi Z; Bajnok A; Szalay B; Toldi G; Kovacs L; Balog A
Pathobiology; 2018; 85(3):201-210. PubMed ID: 29212085
[TBL] [Abstract][Full Text] [Related]
3. Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.
Xueyi L; Lina C; Zhenbiao W; Qing H; Qiang L; Zhu P
J Clin Immunol; 2013 Jan; 33(1):151-61. PubMed ID: 22926407
[TBL] [Abstract][Full Text] [Related]
4. Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients Naïve for TNF blockers.
Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Plasencia-Rodríguez C; Villalba A; Sánchez-Mateos P; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
PLoS One; 2014; 9(9):e107086. PubMed ID: 25203742
[TBL] [Abstract][Full Text] [Related]
5. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A
Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401
[TBL] [Abstract][Full Text] [Related]
6. TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis.
Yang M; Lv Q; Wei Q; Jiang Y; Qi J; Xiao M; Fang L; Xie Y; Cao S; Lin Z; Zhang Y; Tu L; Zhao M; Pan Y; Jin O; Gu J
Arthritis Res Ther; 2020 Jun; 22(1):149. PubMed ID: 32560733
[TBL] [Abstract][Full Text] [Related]
7. Predictive Values of Blood Type I and Type II Interferon Production for Disease Activity and Clinical Response to TNF-α Blocking Therapy in Patients with Ankylosing Spondylitis.
Hu Y; Lou B; Jiang Z; Yu C
Tohoku J Exp Med; 2023 Jul; 260(3):263-271. PubMed ID: 37081619
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
9. Predictive values of circulating miR-146a and miR-155 for disease activity and clinical response to TNF-α blocking therapy in patients with ankylosing spondylitis.
Liu L; Hu X
Int J Rheum Dis; 2024 Jan; 27(1):e15004. PubMed ID: 38152051
[TBL] [Abstract][Full Text] [Related]
10. Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine.
Son SM; Choi SH; Shin JK; Goh TS; Lee JS
Eur Spine J; 2019 Apr; 28(4):649-657. PubMed ID: 30742244
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis.
Prajzlerová K; Komarc M; Forejtová Š; Pavelka K; Vencovský J; Šenolt L; Filková M
Physiol Res; 2021 Apr; 70(2):255-264. PubMed ID: 33676382
[TBL] [Abstract][Full Text] [Related]
12. In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis.
Limón-Camacho L; Vargas-Rojas MI; Vázquez-Mellado J; Casasola-Vargas J; Moctezuma JF; Burgos-Vargas R; Llorente L
J Rheumatol; 2012 Apr; 39(4):830-5. PubMed ID: 22337239
[TBL] [Abstract][Full Text] [Related]
13. Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers.
Nam EJ; Lee WK
Medicine (Baltimore); 2020 Oct; 99(41):e22668. PubMed ID: 33031332
[TBL] [Abstract][Full Text] [Related]
14. Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis.
Fattahi MJ; Ahmadi H; Jafarnezhad-Ansariha F; Mortazavi-Jahromi SS; Rehm BHA; Cuzzocrea S; Matsuo H; Mirshafiey A
Biomed Pharmacother; 2018 Apr; 100():495-500. PubMed ID: 29477913
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis.
Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J
J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of Jitongning Capsule () in patients with ankylosing spondylitis.
Wang YY; Lu H; Zhao Z; Huang F
Chin J Integr Med; 2013 Feb; 19(2):98-103. PubMed ID: 23371457
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-α therapy on sleep problems: A polisomnographic study.
Karatas G; Bal A; Yuceege M; Firat H; Gurcay E; Ardic S; Cakci FA
Int J Rheum Dis; 2018 Jun; 21(6):1263-1269. PubMed ID: 28556500
[TBL] [Abstract][Full Text] [Related]
18. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
Prince DS; McGuigan LE; McGirr EE
Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.
Kwon SR; Lim MJ; Suh CH; Park SG; Hong YS; Yoon BY; Kim HA; Choi HJ; Park W
Rheumatol Int; 2012 Aug; 32(8):2523-7. PubMed ID: 21833531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
